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Glutathione transferase (GST) A2-2 is the most effi-
cient human enzyme in the biotransformation of the
prodrug azathioprine (Aza). The activation of Aza
has therapeutic potential for possible use of GSTs
in targeted enzyme-prodrug treatment of diseases.
Based on the assumed catalytic mechanism and
computational docking of Aza to the active site of
the enzyme, active-site residues were selected for
construction of focused mutant libraries, which
were thereafter screened for Aza activity. Mutants
with elevated Aza activity were identified, DNA
sequenced, and the proteins purified. The two most
active mutants showed up to 70-fold higher catalytic
efficiency than the parental GST A2-2. The structure
of the most active triple mutant (L107G/L108D/
F222H) enzyme was determined by X-ray crystallog-
raphy demonstrating significant changes in the
topography of the active site facilitating productive
binding of Aza as a substrate.INTRODUCTION
Enzymes are nature’s catalysts evolved for biochemical reac-
tions. Even though natural enzymes are adapted to their partic-
ular function in vivo, their use in industrial or pharmaceutical
applications often requires a redesign for proper performance.
Moreover, owing to the complexity of enzyme catalysis
(Hammes-Schiffer and Benkovic, 2006), enzyme engineering
has been considered as one of the most challenging problems
of contemporary biochemistry. Among all methodologies for
enzyme engineering, directed evolution is probably the most
successful and most frequently used approach. By subjecting
members of a mutant library to the power of Darwinian evolution,
enhanced enzyme performance can be achieved by conven-
tional directed evolution strategies even in the absence of struc-
tural information. Despite extensive application of directed
enzyme evolution for tailoring biocatalysts for organic synthesis
or biosynthesis of high-value pharmaceutical intermediates
(Zhang et al., 2010a; Schmidt-Dannert et al., 2000; Savile
et al., 2010; Ran et al., 2004; Bartsch et al., 2008), production
of alternative biofuels (Fasan et al., 2011; Atsumi and Liao,414 Chemistry & Biology 19, 414–421, March 23, 2012 ª2012 Elsevie2008), development of laundry detergent additives (Cherry
et al., 1999), and cancer therapy (Chen et al., 2008; Liu et al.,
2009), several fundamental questions with regard to directed
evolution still need to be addressed.
Directed evolution comprises iterative cycles of randomization
and screening. Theoretically, generation of molecular diversity
by introducing point mutations is not a technical constraint for
directed evolution. Various attempts have been tried to generate
libraries with mutation rates exceeding 30 mutations per protein
using error-prone PCR (Zaccolo and Gherardi, 1999). The result-
ing immense number of library members therefore has increased
the demand for high-throughput enzyme assays. Features of
all available high-throughput screening or selection methods
have been reviewed in detail elsewhere (Lin and Cornish, 2002;
Aharoni and Tawfik, 2009). However, the success of these
approaches is partly dependent on convenient selection or
screening methods based on binding affinity or fluorescence
detection. There is still no general solution to the assay of cata-
lytic turnover numbers via high-throughput assays. An assay
directly based on monitoring product formation is still the
typical scenario, representing the most significant bottleneck
in directed evolution (Dietrich et al., 2010).
Smarter strategies for construction of small mutant library
with high quality, therefore, are receiving increasing attention
(Shivange et al., 2009; Reetz et al., 2009). Inspired by de novo
computational enzyme design (Jiang et al., 2008), reaction
mechanisms can be coupled with directed evolution so that
small focused mutant libraries rationalized by reaction mecha-
nisms can be generated to reduce the screening effort.
In the present work, we tested the utility of such a strategy for
enhancing the efficiency of a glutathione transferase (GST) in the
bioactivation of azathioprine (Aza). Activation of Aza has medical
interest in possible applications of targeted enzyme-prodrug
therapy of diseases. Structural modeling of the enzyme-
substrate complex was obtained by molecular docking of Aza
to the protein. After outlining the possible catalytic mechanism
of the reaction, enzyme-substrate interactions assumed to
stabilize the transition state were considered. On the basis of
this analysis three residues were selected for simultaneous
mutagenesis. A corresponding triple mutant library, randomized
with reduced amino acid alphabets (two amino acid residues
randomized with NDT [D: A/G/T] degenerate oligonucleotides
and one other residue randomized with YHC degeneracy
[Y: C/T; H: A/C/T]), with a theoretical size of 864 members
(12*12*6) was generated and screened for Aza activity. One of
the evolved GST variants displayed a 70-fold increase inr Ltd All rights reserved
Figure 1. Reaction of Azathioprine with Glutathione Catalyzed by GSTs
The toxic antimetabolite 6-mercaptopurine is released via a tetrahedral intermediate formed by nucleophilic attack of the glutathione thiolate (GS). The reaction
is presumed to be promoted by H-bonding or other polar interactions indicated by dashed lines to the intermediate.
See also Figure S1A.
Chemistry & Biology
Structure-Based Redesign of GST A2-2catalytic efficiency relative to the starting-point GST. Other
active-site residues of the parental enzyme in close proximity
to the substrate were further randomized to assess their impor-
tance for activity with the targeted substrate. However, not
a single mutant with enhanced Aza activity was obtained. Finally,
the crystal structure of the new GST mutant was determined,
demonstrating an altered topology of the active site that facili-
tates productive binding of the substrate.
RESULTS
Design of a Focused GST Library
The H-site of human GST A2-2 is composed of 13 amino acid
residues. We hypothesized that simultaneous introduction of
multiple mutations in the active site might introduce novel
catalytic components specifically for the desired substrate.
When we examined the composition of the H-site, proline-110
seemed to be broadly conserved among Alpha class GST isoen-
zymes. One naturally occurring allelic GST variant (GST A2-2*E)
containing a mutation at this position happened to be 3.7-fold
more active with Aza than the allelic variants presenting proline
at position 110 (Zhang et al., 2010b). Therefore, we used GST
A2-2*E (A2*E) as a parent for further evolution.
The GST-mediated conjugation of GSH with azathioprine is
an aromatic substitution (SNAr) involving nucleophilic attack by
the sulfur of GSH on the electrophilic center at carbon 5 of the
imidazole ring (Figure 1). We considered two possible mecha-
nisms to enhance the reaction rate: (1) increasing the partial
positive charge of carbon 5 by increasing the resonance effect
of the adjacent nitro group, or (2) stabilizing the reaction interme-
diates by interaction with the sulfur atom of Aza or the thiolate
group of glutathione (Figure 1). To achieve such effects, novel
interactions between side chains of different active-site residues
and the nitro group or sulfur atomswere aimed for by introducing
novel residues in the active site.
Computer modeling of the binding of Aza to the H-site of
human GST A2-2 was performed, and all docking poses consid-
ered reasonable for catalysis were subjected to further analysis
(Figure S1A available online). Candidate residues were identified
on the basis of proximity to the nitro group of the imidazole
moiety of Aza, the sulfur linkage between the two aromatic rings,
or the sulfur of glutathione. For various docking poses, Leu-107,
Leu-108, Phe-111, and Phe-222 of the active-site residues were
in proximity to the above-mentioned atoms within a distance of
5 A˚. Three focused libraries were constructed with reducedChemistry & Biology 19, 4amino acid alphabets: one targeting three positions 107, 108,
and 222, encoding Arg, Asn, Asp, Cys, Gly, His, Ile, Leu, Phe,
Ser, Tyr, Val (with NDT degeneracy) at each of positions 107
and 108, and His, Leu, Phe, Pro, Ser, Tyr (with YHC codon
randomization) at position 222. The second and third libraries
explored the impact of positions 111 and 213 by separate
libraries based on NDT codon randomization.
Construction of a Triple-Point Mutant Library and
Preliminary Screening for Aza Activity
A dual-tube megaprimer approach was used for focused
mutagenesis (Tseng et al., 2008). By randomly sequencing
more than 40 clones derived from the constructed library, not
a single clone corresponding to the wild-type gene was found,
indicating that adequate variability of the mutations had been
achieved. Thereafter, the constructed library was expressed in
Escherichia coli and subjected to screening for Aza activity.
Lysates of 1901 randomly picked bacterial colonies, and 19
colonies of the wild-type gene as positive controls, were
prepared and assayed with Aza. The experimental coverage
of the mutant library was estimated by Monte Carlo simulation
to be 89% ± 1% (768 ± 8 unique variants of the 864 possible
variants). The activity of the starting GST with Aza was 16.0 ±
4.0 (103DA320/min). The frequency distribution of activity was
skewed to the right with the highest frequency occurring
around the wild-type value, indicating that a randomly chosen
mutant would be more prone to have increased activity
with Aza (Figure 2). 44.2% (840 out of 1901) transformants
exhibited enhanced activity (the cutoff value was set at
mean + 3 SD) with Aza compared to the starting enzyme. Over-
representation of active variants indicated that a high coverage
of the relevant protein sequence space was achieved in the
screening process.
Thirteen variants with activities >200 (103DA320/min) were
sequenced to explore the mutations affording enhanced activity
with azathioprine. Sequence information on these mutants can
be found in Table S2. All of the 13 mutants contained targeted
residue alterations and no spurious mutations. However, one
of the isolates (TP10_12E) turned out to be a mixture of two
distinct GST sequences containing the triple mutations L107G/
L108D/F222P (mutant GDP) and L107G/L108D/F222H (mutant
GDH), both of which were represented separately among
the most active mutants identified (Table S2). Substitutions
occurring in the sequences of the most active variants, largely
led to charged or hydrophilic side chains.14–421, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 415
Figure 2. Frequency Distribution of Aza activity
in Bacterial Lysates of the GST Mutant Library
Screened
Activities are given in absorbance units as measured
in 300 ml reaction volumes in microplates. The histogram
was constructed with a bin interval of 4 (103DA320/min
activity units); the activity of the parental GST A2-2*E
was 16.0 ± 4.0 units.
See also Table S2.
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Two additional mutant libraries targeting active-site residues
111 and 213, one at a time, were constructed with NDT degen-
eracy of the codons. Neither mutations of one nor the other in
the A2*E wild-type background gave rise to any GST mutants
with enhanced Aza activity in bacterial lysates.
Kinetic Characterization of Selected GST Variants
Nine variants of the above-mentioned sequenced GST pro-
teins, as well as three additional variants chosen based on
end-point assays, were expressed and purified. Enzyme reac-
tion rates with Aza in bacterial lysates were from 178 to 336
(103DA320/min) for all variants examined. All purified protein
variants exhibited enhanced specific activities by a factor
from 7 to 56 compared to the parental enzyme A2*E. However,
the ratio between lysate activity to specific activity of purified
GST mutants varied up to 10-fold among the 12 variants inves-
tigated, even though 9 out of 12 variants exhibited a similar
ratio as that of the parental GST. Apparently, expression levels
of the enzyme protein varied among the mutants (Figure 3).
Although the observed increases in lysate activities stemmed
from differences both in intrinsic enzyme activities and ex-
pression levels, the main factor was the enhanced specific
activities. The L107C/L108S/F222H mutant (CSH, designating
the new residues of the mutated positions in one-letter
amino acid code) and the L107C/L108G/F222H mutant (CGH)
were two GST variants with enhanced expression levels, while
their specific activities were only moderately increased. A third
mutant GDH displayed a 50% decrease in expression
compared to that of the parental enzyme. The two most active
variants (GDH and GDP) differed only in one amino acid
residue, both having Gly and Asp at positions 107 and 108,
respectively. The purified GDH exhibited a specific activity of
128 mmol min1 mg1 with Aza, approaching the upper limit
of known activities of the GST scaffold (Table 1).416 Chemistry & Biology 19, 414–421, March 23, 2012 ª2012 Elsevier Ltd All rights reA2*E as well as the two most active variants
GDH and GDP were then subjected to steady-
state kinetic studies, in which the mutants
showed 70- and 40-fold enhanced catalytic
efficiencies with Aza, respectively (Table 2).
The gains in catalytic efficiency stemmed from
both increased kcat and decreased KM, as an
indication of enhanced substrate recognition.
Thermal Inactivation and pH-Rate
Profiles of the Selected GST Variants
Thermal inactivation and effect of pH on enzyme
activity of the parental A2*E, GDP and GDHwere also investigated (Figure 4A). Thermal inactivation of A2*E
and GDP displayed half-lives estimated at 21 and 12 days at
37C, respectively. In contrast, thermal denaturation of GDH
displayed two phases, with a slow phase resulting in a loss of
50% of activity after incubation for 8 days. These results
evidenced a negative tradeoff between the enhanced activity
and thermostability in the evolved enzymes, which is often
observed in laboratory enzyme evolution (Romero and Arnold,
2009).
The pH-rate profiles of all GST variants investigated largely
coincided, with maximum activity exhibited around pH 7 (Fig-
ure 4B). In particular, the similarity between the profiles of A2*E
and GDH at low pH values suggested that ionization of His-
222 is not a contributing factor to the elevated activity of GDH.
Structural Studies of the Evolved GST Mutant
The GDH mutant was crystallized with the imidazole conjugate
of glutathione (S-1-methyl-4-nitro-5-imidazolyl-glutathione) re-
sulting from the reaction with Aza followed by X-ray analysis
(Table S3). The crystal unit cell contained two dimeric GST struc-
tures showing expected similarities with the GST A2-2 enzyme
previously studied (Tars et al., 2010). However, the human
enzyme occurs in five allelic variants (Zhang et al., 2010b) and
the previous structure represents the C allele (GST A2*C), which
is 3.7-fold less active with Aza than the A2*E variant chosen for
mutagenesis in the present study. Comparison of the two struc-
tures shows that Pro-110 in A2*C causes the polypeptide chain
to restrict the active-site cavity to a smaller volume than that of
the GDH mutant derived from A2*E which features Ser-110 in
the same position (Figure 5). Apparently, this structural differ-
ence underlies the divergence between the allelic variants in
the activities with Aza. There is also a difference in position
112 (Thr and Ser in allelic variants C and E, respectively), but
this conservative replacement of a side chain pointing away
from the active site is not likely to influence the activity.served
Figure 3. Radar Chart Illustrating Expression Levels of GSTMutants
in E. coli Relative to That of the Parental GST A2-2*E
The three letter designations identify the amino acids (in one-letter code) in
positions 107, 108, and 222 of the primary structure. The length of a spoke is
proportional to the natural logarithm of the expression relative to that of A2*E
(LLF). The values were calculated from the ratio between lysate activity to
specific activity for each variant.





Positions 107 108 222
Specific Activity
(mmol mg1 min1)
A2*E L L F 2.3 ± 0.1
TP01_1F V G S 59 ± 3
TP02_1E C S H 16 ± 1
TP03_10D S D P 49 ± 1
TP04_3H G D P 86 ± 1
TP04_9H G N P 48 ± 2
TP08_6A H S H 49 ± 2
TP09_3G C G H 19 ± 1
TP10_6B G S H 34 ± 1
TP14_4F V G P 50 ± 1
TP15_6D G D H 128 ± 4
TP15_12G S G P 64 ± 5
TP16_1E H G P 65 ± 5
For oligonucleotides used in generating the library (see also Table S1).
Table 2. Catalytic Efficiency of Selected Variants with Aza
Aza kcat (s
1) KM (mM) kcat/KM (mM
1 s1)
A2*E 12.7 ± 1.6 3.1 ± 0.5 4.1
GDH 145 ± 9 0.50 ± 0.06 292
GDP 86 ± 4 0.48 ± 0.04 180
Data are represented as mean ± standard deviation and are based on
triplicate measurements.
The kcat and kcat/KM values are expressed per subunit of the dimeric
enzyme.
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S-1-methyl-4-nitro-5-imidazolyl-glutathione, only the gluta-
thione moiety was clearly visible in the electron density. Its posi-
tion and conformation were highly similar to that of glutathione in
the A2*C enzyme, in basic agreement with the coordinates used
for the modeling prior to mutagenesis (Figure S1A). It is likely
that the imidazolyl portion of the glutathione conjugate is not
bound in a fixed position, and is therefore not observable in
the active site.
His-222 in GDH is located in essentially the same position
as Phe-222 in wild-type GST A2-2, but in both proteins residue
222 is more mobile than other active-site residues, as judged
by less well-defined electron density. His-222 is too far away
to directly influence the reactivity of the glutathione sulfur
atom, consistent with the unchanged pH-activity profile of
GDH in comparison with the wild-type enzyme (Figure 4B).
Residues 107 and 108 in GDH demonstrate the most
conspicuous differences from the wild-type GST, which
features Leu-107 and Leu-108. In the wild-type enzyme the
side chains of both residues point toward bound hydrophobic
substrates. Replacement of Leu-107 by Gly removes the
bulky hydrophobic side chain and provides additional space
in the active-site cavity. An even more dramatic alteration of
the active site occurs in position 108 where the polar Asp-
108 is introduced. The side chain of Asp-108 in the GDH
structure is directed toward Lys-120, apparently making
an ionic bond with its side-chain ammonium group. In this posi-
tion the carboxyl group of Asp-108 is far removed from the
sulfur of glutathione, but creates additional room for substrate
binding.Chemistry & Biology 19, 4DISCUSSION
One of the most intriguing problems in biochemistry is enzyme
engineering, not only because of numerous technical challenges
for rational design and directed evolution, but also due to
extensive applications in medicine, synthetic chemistry, phar-
maceutical development and agricultural sciences. In spite of
recent achievements in computational enzyme (re)design
(Jiang et al., 2008; Murphy et al., 2009; Ro¨thlisberger et al.,
2008; Siegel et al., 2010), the intricacy of predicting allosteric
effects and taking structure dynamics and substrate/product
affinities into consideration imposes limitations to the perfor-
mance of computational (re)design with regard to rate enhance-
ment as compared to that of directed evolution (Golynskiy and
Seelig, 2010). In contrast, by randomizing a rigid secondary
element in the interface between the FAD-NADP domains of
a thermostable Baeyer-Villiger monooxygenase (PAMO), Reetz
and co-workers successfully introduced allosterically induced
domain movements to expand the substrate specificity of the
enzyme by a directed evolution approach (Wu et al., 2010).
Although large libraries allow extensive exploration of sequence
space, which may facilitate identification of desired enzyme vari-
ants, screening efforts currently constitute the major bottleneck
for directed enzyme evolution. Despite recent progress including
in vitro display techniques, in vivo selection systems, in vitro14–421, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 417
Figure 4. Thermal Inactivation and pH-Rate
Profiles of Wild-Type GST A2-2*E and
Mutants GDH and GDP
(A) Thermal inactivation test progress of GST
variants. Enzyme at a concentration of 0.1 mg/ml
was incubated in 100 mM sodium phosphate (pH
7.4) in the presence of 1mMGSHat 37C. Aliquots
of the incubation mixture were taken at different
time points and assayed for residual specific
activity. The error bars represent the standard
deviation based on three replicates.
(B) pH activity profiles indicating neutral pH optima of GST variants. Enzymes were assayed in the standard system for specific activity, with the exception
that the pH of the 100 mM sodium buffer was varied. The error bars represent the standard deviation based on three replicates.
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based screening methods directly monitoring product formation
are typically more versatile. In order to reduce the screening
effort of simultaneous multisite saturation mutagenesis, the
group of Bornscheuer proposed randomization of targeted
residues with the most frequently naturally occurring amino
acids in the quest for thermostabilized Pseudomonas
fluorescens esterase (Jochens et al., 2010). Generation of such
small high-quality libraries for ease of screening is therefore
starting to gain increased attention as a means to exploring
sequence space more efficiently (Alcolombri et al., 2011; Ja¨ckel
et al., 2008).
In this work, we integrated molecular docking and reduced
amino acid alphabets for enzyme engineering. By examining
all possible substrate orientations (Figure S1A), we identified
three hot spots (positions 107, 108, and 222) for randomization
on the basis of the underlying catalytic mechanism (Figure 1).
Simultaneous randomization of the three positions for a
complete set of amino acids using NNK codon degeneracy
would result in a mutant library of 323 members, which would
be very time consuming with regard to the screening effort in
the absence of high-throughput methods (even disregarding
the need for oversampling to achieve a necessary coverage
of protein sequence space). The merits of using NDT random-
ization in combinatorial protein engineering have been demon-
strated by Reetz et al. (2008, 2009). Consequently, residues
107 and 108 were randomized with NDT degeneracy. A pre-
vious study indicated an important role of the bulky Phe-222
for catalysis (Nilsson et al., 2002), and residue 222 was there-
fore randomized with YHC degeneracy, mainly leading to large
side chains at this position. In addition, the chosen codon
degeneracies limited the number of possible combinations to
864, thereby facilitating the screening. By such randomization
of three residues of the 13 active-site residues in the parental
GST, followed by screening, we successfully enhanced GST
activity with Aza by 70-fold.
The rate-limiting step and the transition state of the GST-cata-
lyzed reaction with Aza are unknown, even though the tetrahe-
dral intermediate shown in Figure 1 should exist on the reaction
trajectory. Elucidation of the detailed mechanism would require
further investigations. The most obvious consequence of the
mutations is an enlarged H-site, which facilitates accommoda-
tion of the purine ring of Aza. The crystal structure of mutant
GDH does not support our postulate that the mutated residues
directly polarize functional groups of the imidazole moiety of
Aza and thereby enhance catalytic efficiency. The side chains418 Chemistry & Biology 19, 414–421, March 23, 2012 ª2012 Elsevieof the four mutated amino acids are too far removed from the
reaction center for direct interactions. Molecular docking of
Aza to mutant GDH indicates possible interactions between
Arg-15 and Glu-104 with Aza, but the analysis does not imply
any direct interaction between the side chains of the four
mutated amino acids in GDH and Aza (Figure S1B). However, it
should be noted that a rigid model of protein mutant GDH was
used in the docking analysis, and the dynamic behavior of the
protein is thus not accounted for. It can be speculated that the
negatively charged Glu-104, directly or indirectly, promotes
Aza activation. The notion of a negative charge enhancing cata-
lytic efficiency is also indicated by site-directed mutagenesis of
Leu-108 in A2*E to Asp (data not shown). Furthermore, the
back-mutation of Asp-108 in GDH to Leu (data not shown) has
confirmed the activating effect of the negatively charged side
chain. Possibly, the enhanced function of the active site is
primarily based on electrostatic stabilization of the transition
complex, as argued in general for enzyme catalysis by Warshel
et al. (2006), and not by provision of novel catalytic groups. A
70-fold enhanced catalytic efficiency corresponds to a DDGz of
2.5 kcal mol1 transition state stabilization. We are currently
working on a model for the activated reaction intermediate and
the transition state.
In retrospect, it would appear that our strategy of mutating
residues in the required proximity to Aza involved the most
reasonable choices of a total of seven active-site amino acids:
Arg-15, Leu-107, Leu-108, Phe-111, Leu-213, Phe-220, and
Phe-222. Arg-15 is functionally significant and conserved in
alpha class GSTs (Bjo¨rnestedt et al., 1995) and Phe-220 is part
of the glutathione binding site (Bruns et al., 1999) and they
were therefore excluded from mutagenesis. Phe-111 and Leu-
213 in A2*E were separately randomized with NDT and NNK
codon degeneracy, respectively, but only variants with dimin-
ished Aza activity were found after screening of >600 clones.
Early dead ends of directed enzyme evolution can occur not
only because of evolutionary traps caused by loss of catalytic
efficiency, but also may be due to accumulation of destabilizing
mutations in the evolutionary paths. Enzymes are only marginally
stable with DGfold of about 5 to 15 kcal mol1 (Williams et al.,
2006; Fersht, 1999). Moreover, the flux of destabilizingmutations
is considered > 20-fold larger than that of stabilizing mutations
(Tokuriki and Tawfik, 2009). In other words, from the perspective
of thermodynamic stability only a handful of mutations should
be introduced simultaneously in order for the majority of
the library members to be properly folded and structured.
Thermodynamic effects of new-function mutations seem to ber Ltd All rights reserved
Figure 5. Comparison of the Active Sites of
Allelic Variant C of Human GST A2-2 and
Mutant GDH of Allelic Variant E
Glutathione (rendered as a stick model with black
carbons) points its nucleophilic sulfur toward the
H-site (marked ‘‘H’’), which binds the electrophilic
second substrate. Four residues (107, 108, 110,
and 222) differing between the two structures
(stick models with green carbons) define the
H-site cavity, in which Aza is supposed to bind
with the imidazole leaving group close to the
attacking sulfur of glutathione. The large purine
moiety of Aza has more space in the H-site of
the GDH mutant since the bulky Leu side chains
have been removed. Figure was made in Pymol (The PyMOL Molecular Graphics System, Version 1.3, Schro¨dinger, LLC). Active sites of allelic variant C of
human GST A2-2 (left, PDB code 2WJU) and mutant GDH of allelic variant E (right, present study, PDB code 4ACS).
See also Figure S1B and Table S3.
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GST, the average value of DDGfold for each new-function muta-
tion is 2.08 kcal mol1 (Tokuriki et al., 2008). Accordingly, no
more than five mutations would be tolerated for GST reengineer-
ing, in the absence of compensatory stabilizing mutations. Iden-
tifying the active-site residues crucial for catalysis is therefore
a key to successful evolutionary design.
SIGNIFICANCE
The current work has integrated the assumed reaction
mechanism and molecular docking into a general semira-
tional enzyme engineering approach. As a result, high
frequency of mutant variants with enhanced activity was
achieved. By simultaneously introducing three mutations,
an enzyme variant was discovered exhibiting a specific
activity and kcat value approaching the upper limits of these
parameters known for the GST scaffold. Moreover, the
approach was experimentally proven to be more successful
for the improvement of enzyme performance than intuitively
choosing active-site residues such as residues 111 and 213
in proximity to the substrate. Considering the importance of
pinpointing crucial residues for enhancement of enzyme
performance, we believe that such a semirational approach
is a valuable strategy for enzyme engineering. In our applica-
tion, a GST with the targeted enhanced efficiency in the
activation of the prodrug Aza was accomplished.
EXPERIMENTAL PROCEDURES
Materials
Pfu DNA polymerase and DpnI restriction nuclease were purchased from
Stratagene and Fermentas, respectively. QIAquick gel extraction kit was
from QIAGEN. Oligonucleotides used were ordered from Thermo Fisher
Scientific. E. coli XL1-Blue obtained from Stratagene was used for protein
expression. All chemical substrates were purchased from Sigma-Aldrich.
Automated Docking
Azathioprine input file was generated at DockingServer, with ligand partial
charged and geometry refined by semiempirical methods (PM6) (Bikadi and
Hazai, 2009). A structural model for GST A2-2*E (A2*E) was created from the
structure of GST A2-2*C (PDB code: 2WJU; Tars et al., 2010) using the
Swiss-Pdb Viewer software (Guex and Peitsch, 1997). Hydrogen atoms
were added to the holo structure of A2*E using Auto Dock Tools 1.5.1 (Morris
et al., 1998). A grid box of 503 503 50 points spaced at 0.375 A˚, centered onChemistry & Biology 19, 4the center of H-site covering the hydrophobic ligand-binding site, was con-
structed for the docking of azathioprine. Using AutoDock 4.0, a combined
global and local search algorithm through a Lamarckian genetic algorithm
(LGA) was used to determine the docked conformations. Two hundred runs
were performed for genetic algorithms, with a population size of 250,
540,000 as maximum number of generations, and other parameters with
default values. The default parameters were used for local search. To analyze
the docked conformations, the cluster tolerance of RMSD was 0.5 A˚, so only
conformations within this restriction would be subgrouped into the same
cluster.
Construction of a Multiple Site-Directed Mutagenesis Library
Plasmid pGDETac_NHis_hA2*E was used as the template to construct a
focused mutagenesis library. Detailed information about primers can be
found in Supplemental Information (Table S1).
A dual-tube approach was used for the construction of the mutant library
(Tseng et al., 2008). The first-stage amplification reaction was performed in
a total volume of 100 ml, containing 40 ng template plasmids, 10 pmol of oligo-
nucleotides, 10 nmol of dNTP and 2.5 U of Pfu DNA polymerase. After initial
denaturation at 95C for 5 min, the first-stage amplification was carried out
by 24 cycles of 95C for 30 s, 55C for 30 s, 72C for 60 s, and final extension
at 72C for 10 min. For further extension from PCR product as megaprimers
with desired mutations to whole plasmid, the reaction was performed in a total
volume of 50 ml, containing 40 ng of template plasmids, 10 ml of purified PCR
product from the first-stage amplification as primers, 10 nmol of dNTP and
1.25 U of Pfu DNA polymerases. After denaturation of dsDNA at 95C for
5 min, 30 cycles of denaturation at 95C for 30 s, annealing at 68C for 30 s,
and extension at 72C for 4 min were carried out, followed by final extension
at 72C for 10 min. After DpnI digestion of the template plasmids at 37C for
8 hr, 2 ml of DpnI-treated DNA was electroporated into E. coli XL1-Blue, and
transformants were selected on ampicillin-containing (100 mg/ml) LB plates.
Preparation of Bacterial Lysates
A total of 1,920 single colonies (including 19 parental colonies as positive
controls) were randomly picked and incubated in 96-well microtiter plates
with 250 ml LB medium supplemented with 100 mg/ml ampicillin. After incuba-
tion at 37C for 16 hr, and centrifugation at 500 rpm for 3 min to avoid potential
contamination, colonies from the bacterial cultures were diluted 100-fold
into 400 ml/well plates containing 300 ml 2TY supplemented with 100 mg/ml
of ampicillin. Bacteria were grown for protein expression at 37C for 17 hr in
the absence of IPTG. For complete lysis, cultures were pelleted, resuspended
in 150 ml 100 mM sodium phosphate buffer (NaPi [pH 7.0], with 0.2 mg/ml
lysozyme), then incubated on ice for 1 hr, followed by three cycles of
freezing/thawing (80C /37C). The lysates then were centrifuged and the
supernatants were used for activity measurement in microtiter plates. The
experimental coverage of the library was estimated by Monte Carlo simulation
using 10,000 iterations using a commercial software package (MATLAB 7.5,
The MathWorks Inc., Natick, MA, 2007) and presented as mean ± standard
deviation.14–421, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 419
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For the screening of GST activity with azathioprine, 5 ml centrifuged bacterial
lysate, 1 mM GSH (final concentration), 0.2 mM azathioprine (final concentra-
tion) and NaPi buffer (100 mM [pH 7.0]) were added to a total volume of 250 ml
in microtiter plate wells. The change in absorbance at 320 nm was directly
proportional to GST activity with azathioprine, and the activity of 5 ml lysate
was expressed in the unit of 103DA320/min.
Protein Expression and Purification
For cytosolic overexpression of GST variants in E. coli, overnight cultures
were transferred into 500 ml 2TY medium with 100 mg/ml ampicillin at a
1:100 dilution, and grown to an OD600 of 0.3 before induction for 14 hr
with 0.2mM IPTG. Cells were pelleted and lysed by lysozyme at a final concen-
tration of 0.2 mg/ml for 60 min on ice, then subjected for sonication for
complete lysis. After centrifugation at 27,200 3 g for 60 min at 4C, superna-
tants were loaded on His GraviTrap columns for purification. The purified
enzymes were dialyzed overnight against Tris-EDTA-mercaptoethanol (TEM)
buffer (50 mM Tris, 0.5 mM EDTA, 50 mM NaCl, 1 mM 2-mercaptoethanol,
5% glycerol [pH 7.4]). Protein purity was then verified by SDS-PAGE. The
purified protein concentration was determined through Bradford assay with
the protein assay reagents from Bio-Rad, with bovine serum albumin as
a protein standard.
Determination of Specific Activity and Kinetic Parameters
Detailed description of the spectrophotometric enzymatic assays has been
published previously (Zhang et al., 2010b; Eklund et al., 2006). Kinetic param-
eters were determined by fitting the Michaelis-Menten equation to initial
velocity data using GraphPad Prism 5. The kcat values are expressed per
subunit of the dimeric enzyme.
Crystallization and Structure Determination of the GDH Mutant
The mutant GDH was crystallized by the hanging-drop vapor-diffusion
method. The mutant protein was purified as described above. After buffer
replacement to 10 mM Tris-HCl (pH 7.8), the protein was concentrated
by ultrafiltration. The final solution for crystallization contained protein at
10 mg/ml and 5 mM S-1-methyl-4-nitro-5-imidazolyl-glutathione in 10 mM
Tris-HCl (pH 7.8). The glutathione S-conjugate was synthesized from 5-
chloro-1-methyl-4-nitroimidazole and glutathione essentially as described
for S-hexyl-glutathione (Vince et al., 1971; Aronsson and Mannervik, 1977).
Crystals were grown by mixing equal volumes (4 ml) of protein – glutathione
S-conjugate mixture and reservoir solution containing 9%–14% PEG 4000
and 2mMDTT in 100mMTris-HCl (pH 7.8) with additional octyl D-b- glucopyr-
anoside to a final concentration of 0.1% (w/v). Diffraction data were collected
from beamline ID14-2 at the ESRF synchrotron (Grenoble, France). Data were
indexed with MOSFLM (Leslie, 1992) and scaled using SCALA (Evans, 1997).
The structure was solved by molecular replacement in MOLREP (Vagin and
Teplyakov, 1997) using native GST A2-2 coordinates (PDB code 2WJU; Tars
et al., 2010) as a starting model. The space group was P21 with unit cell
dimensions a = 48.6 A˚, b = 94.8 A˚, c = 113.7 A˚ and b = 92.8. There were
two GST dimers in the unit cell. Mutated residues were built in COOT (Emsley
et al., 2010) and structure refined with REFMAC (Murshudov et al., 1997).
Processing, refinement and validation statistics are shown in Table S3.
Coordinates and structure factors have been deposited in the PDB databank
with accession code 4ACS.
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